SEC Filings

Form 10-K
IRHYTHM TECHNOLOGIES, INC. filed this Form 10-K on 03/04/2019
Document Outline
Entire Document (9657.1 KB)
Subdocument 1 - 10-K - 10-K
Page 1 - UNITED STATES
Page 2 - Table of Contents
Page 3 - SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Page 4 - PART I
Page 5 - The American Journal of CardiologyThe American Journal of Medicine
Page 6 - Stroke
Page 7 - Cardiac Event Monitors and Mobile Cardiac Telemetry
Page 8 - N/A
Page 9 - Key Benefits
Page 10 - Pacing and Clinical Electrophysiology
Page 11 - Value to Payors
Page 12 - Zio monitor
Page 13 - Data Analysis and Assessment
Page 14 - N/A
Page 15 - Reporting Events During the Wear Period with Zio AT
Page 16 - Reimbursement and Revenue from the Zio service
Page 17 - Clinical Results and Studies
Page 18 - Changing Clinical Management for AF
Page 19 - Research and Development
Page 20 - Intellectual Property
Page 21 - Manufacturing and Supply
Page 22 - Pervasive and Continuing Regulation
Page 23 - European Union
Page 24 - Federal, State and Foreign Fraud and Abuse Laws
Page 25 - Open Payments
Page 26 - U.S. Centers for Medicare and Medicaid Services (CMS)
Page 27 - Corporate and Other Information
Page 28 - Our revenue relies substantially on the Zio service, which is currently our only product offering. I
Page 29 - We have noticed seasonality in the use of our Zio service which, along with other factors such as se
Page 30 - If third-party commercial payors do not provide any or adequate reimbursement, rescind or modify the
Page 31 - Our continued rapid growth could strain our personnel resources and infrastructure, and if we are un
Page 32 - We plan to introduce new products and services and our business will be harmed if we are not success
Page 33 - We rely on single suppliers for some of the materials used in our products, and if any of those supp
Page 34 - Billing for our Zio service is complex, and we must dedicate substantial time and resources to the b
Page 35 - We rely on a third-party billing company, XIFIN, to transmit and pursue claims with payors. A delay
Page 36 - The continuing clinical acceptance of the Zio service depends upon maintaining strong working relati
Page 37 - International expansion of our business exposes us to market, regulatory, political, operational, fi
Page 38 - We could be adversely affected by violations of the FCPA, and similar worldwide anti-bribery laws an
Page 39 - N/A
Page 40 - The use, misuse or off-label use of the Zio service may result in injuries that lead to product liab
Page 41 - Consolidation of commercial payors could result in payors eliminating coverage or reducing reimburse
Page 42 - Risks Related to Our Intellectual Property
Page 43 - Intellectual property rights may not provide adequate protection, which may permit third parties to
Page 44 - If our trademarks and tradenames are not adequately protected, then we may not be able to build name
Page 45 - Alice Corp. v. CLS Bank International
Page 46 - N/A
Page 47 - If we fail to obtain and maintain necessary regulatory clearances or approvals for the Zio monitors
Page 48 - Material modifications to the Zio monitors, labelling of the Zio monitors, or Zio service may requir
Page 49 - Zio monitors may in the future be subject to product recalls that could harm our reputation.
Page 50 - Risks Related to Our Common Stock
Page 51 - If securities or industry analysts do not publish research or reports about our business, or publish
Page 52 - Anti-takeover provisions in our amended and restated certificate of incorporation and bylaws, and De
Page 53 - We have not paid dividends in the past and do not expect to pay dividends in the future, and, as a r
Page 54 - PART II
Page 55 - Performance Graph
Page 56 - Item 6. Selected Consolidated Financial Data.
Page 57 - Item 7. Management s Discussion and Analysis of Financial Condition and Results of Operations.
Page 58 - Components of Results of Operations
Page 59 - Interest Expense
Page 60 - Research and Development Expenses
Page 61 - Cost of Revenue and Gross Margin
Page 62 - Cash Flows
Page 63 - Cash Used in Financing Activities
Page 64 - California HealthCare Foundation Note
Page 65 - Allowance for Doubtful Accounts and Contractual Allowance
Page 66 - Estimated Usage of the Printed Circuit Board Assembly
Page 67 - Recent Accounting Pronouncements Not Yet Adopted
Page 68 - Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
Page 69 - Item 8. Financial Statements and Supplementary Data.
Page 70 - Report of Independent Registered Public Accounting Firm
Page 71 - Definition and Limitations of Internal Control over Financial Reporting
Page 72 - IRHYTHM TECHNOLOGIES, INC.
Page 73 - IRHYTHM TECHNOLOGIES, INC.
Page 74 - IRHYTHM TECHNOLOGIES, INC.
Page 75 - IRHYTHM TECHNOLOGIES, INC.
Page 76 - IRHYTHM TECHNOLOGIES, INC.
Page 77 - IRHYTHM TECHNOLOGIES, INC.
Page 78 - Fair Value of Financial Instruments
Page 79 - Concentrations of Risk
Page 80 - Impairment of Long-Lived Assets
Page 81 - Disaggregation of Revenue
Page 82 - Contract Liabilities
Page 83 - Stock-based Compensation
Page 84 - Recent Accounting Pronouncements Not Yet Adopted
Page 85 - 4. Fair Value Measurements
Page 86 - 5. Balance Sheet Components
Page 87 - Property and Equipment, Net
Page 88 - Legal Proceedings
Page 89 - Bank Debt
Page 90 - Future minimum payments
Page 91 - N/A
Page 92 - 9. Stockholders Equity
Page 93 - 2016 Plan
Page 94 - Equity Incentive Plan Activity
Page 95 - 11. Stock-Based Compensation
Page 96 - Non-Employee Stock-Based Compensation
Page 97 - 13. Selected Quarterly Financial Data (unaudited)
Page 98 - Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
Page 99 - Remediation Plan and Other Information
Page 100 - PART III
Page 101 - PART IV
Page 102 - N/A
Page 103 - N/A
Page 104 - N/A
Page 105 - SIGNATURES
Subdocument 2 - EX-10.35 - EX-10.35
Page 1 - OFFICE LEASE
Page 2 - TABLE OF CONTENTS
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - OFFICE LEASE
Page 8 - N/A
Page 9 - N/A
Page 10 - OFFICE LEASE
Page 11 - Business Day:.
Page 12 - Extension OptionExhibit F
Page 13 - Lease Date
Page 14 - N/A
Page 15 - N/A
Page 16 - Original Tenant
Page 17 - Recorded Documents
Page 18 - Target Delivery Date
Page 19 - Tenant Improvement AllowanceArticle 10
Page 20 - Existing Lease
Page 21 - Exhibit C
Page 22 - Additional Rent; Other Payments
Page 23 - "Expense Claim
Page 24 - provided
Page 25 - Landlord s Dispute
Page 26 - Use of Premises.
Page 27 - Landlord ComplianceSection 7.3(b)
Page 28 - Tenant s Measures
Page 29 - Section 4.4(b)
Page 30 - Provision of Additional ServicesSection 8.2
Page 31 - Sections 16.116.2
Page 32 - Ground Floor Lobby and Other Renovations
Page 33 - General Requirements
Page 34 - Notice of Non-Responsibility
Page 35 - provided, however,
Page 36 - Landlord s FeeSection 10.8
Page 37 - Landlord s ElectionSection 12.1Section 12.1Section 12.1Section 12.3Article 12
Page 38 - Condemnation Proceeds
Page 39 - Insurance.
Page 40 - Article 14
Page 41 - Section 16.1Section 16.1Section 16.1
Page 42 - Assignment and Subletting
Page 43 - i
Page 44 - Audit
Page 45 - Recalculation of Base Rent
Page 46 - Rules and Regulations
Page 47 - Section 31.1
Page 48 - Section 20, KitSection 20.1(viii)
Page 49 - Sections 20.2(a)(i)Section (iii)Sections 20.2(a)(i)(ii)(iii)
Page 50 - Section 20.5
Page 51 - Notice to EncumbrancerArticle 28Article 28)
Page 52 - provided, however,
Page 53 - Holding Over
Page 54 - Article 26
Page 55 - provided, however,
Page 56 - Section 26.5Article 26
Page 57 - provided, however,
Page 58 - Waiver of LiabilitySection 15
Page 59 - Communications and Computer Lines and Equipment
Page 60 - General Provisions
Page 61 - No Solicitation
Page 62 - Governing Law
Page 63 - Memorandum of Lease
Page 64 - Exhibits.
Page 65 - Subdivision; Future Ownership
Page 66 - Bankruptcy of Tenant
Page 67 - Certified Access Specialist
Page 68 - Section 33.34 Section 33.34
Page 69 - Rights Personal to Original TenantArticle 34
Page 70 - LANDLORD
Page 71 - EXHIBIT A
Page 72 - N/A
Page 73 - EXHIBIT B
Page 74 - N/A
Page 75 - N/A
Page 76 - EXHIBIT C
Page 77 - N/A
Page 78 - EXHIBIT D
Page 79 - N/A
Page 80 - N/A
Page 81 - EXHIBIT A
Page 82 - EXHIBIT
Page 83 - EXHIBIT E
Page 84 - EXHIBIT F
Page 85 - Arbitration
Page 86 - Exhibit F)Exhibit F
Page 87 - SCHEDULE 1 TO EXHIBIT F
Page 88 - Net Equivalent Rent
Page 89 - EXHIBIT G
Page 90 - flPP
Page 91 - EXHIBIT H
Page 92 - EXHIBIT I
Page 93 - EXHIBIT J
Subdocument 3 - EX-23.1 - EX-23.1
Page 1 - N/A
Subdocument 4 - EX-31.1 - EX-31.1
Page 1 - N/A
Subdocument 5 - EX-31.2 - EX-31.2
Page 1 - N/A
Subdocument 6 - EX-32.1 - EX-32.1
Page 1 - N/A
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE (What's this?)
XBRL Viewer